Table 5.
Changes in Risk Factors Between Baseline and First and Second Follow‐Up Among Participants in the Intervention Program (n=2906 With Complete Data)
| Risk Factor | Baseline (mean±SD) | Follow‐Up I (mean±SD) | Follow‐Up II (mean±SD) | F Value*† (df) | P |
|---|---|---|---|---|---|
| Systolic blood pressure, mm Hg | 139.4±17.8 | 137.1±17.4 | 136.9±17.1 | 31.2 (2, 2904) | <0.001 |
| Diastolic blood pressure, mm Hg | 82.2±9.4 | 80.7±8.9 | 80.0±9.2 | 57.0 (2, 2904) | <0.001 |
| Fasting serum glucose, mmol/L | 5.30±1.65 | 5.07±1.51 | 5.05±1.64 | 47.1 (2, 2845) | <0.001 |
| Hemoglobin A1c, % | 5.83±0.86 | 5.73±0.71 | 5.98±0.70 | 431.2 (2, 2826) | <0.001 |
| Total cholesterol, mmol/L | 5.67±1.03 | 5.60±1.00 | 5.53±1.03 | 27.3 (2, 2844) | <0.001 |
| Low‐density lipoprotein cholesterol, mmol/L | 3.44±0.90 | 3.32±0.87 | 3.25±0.89 | 62.2 (2, 2728) | <0.001 |
| High‐density lipoprotein cholesterol, mmol/L | 1.51±0.41 | 1.56±0.41 | 1.59±0.42 | 119.1 (2, 2839) | <0.001 |
| Triglycerides, mmol/L | 1.62±0.96 | 1.60±0.94 | 1.57±0.88 | 13.7 (2, 2842) | <0.001 |
| Homocysteine, μmol/L | 7.36±3.32 | 6.47±3.71 | 6.62±4.40 | 67.6 (2, 2605) | <0.001 |
| Body mass index, kg/m2 | 27.84±4.39 | 27.73±4.47 | 27.74±4.61 | 6.64 (2, 2898) | 0.002 |
*
Repeated‐measures analysis of variance.
†
Degrees of freedom may differ because of missing data.